Overview of Dexamol Kid

Quick Facts

Property	Description
Active Ingredient	Acetaminophen (Paracetamol)
Pharmacological Class	Analgesic and Antipyretic
Primary Form(s)	Oral Liquid (Syrup/Suspension) and Suppository
Target Audience	Pediatric Population (Children and Infants)
Origin	Synthetic derivative (Para-aminophenol class)

Dexamol Kid is a specialized, single-ingredient medicinal product primarily classified as an Analgesic (pain reliever) and an Antipyretic (fever reducer), meticulously formulated for the pediatric population. The active chemical component is Acetaminophen, widely known as Paracetamol. This medicine is an established Over-the-Counter (OTC) drug, essential for the prompt, at-home management of common childhood symptoms, such as discomfort and fever associated with viral illness.

The active ingredient is a synthetic derivative belonging to the Para-aminophenol class. This compound provides effective relief from general pain and aids in the reduction of fever by modulating signals within the central nervous system. Its efficacy is clinically recognized as a foundational component of pediatric pain and fever management, and it is utilized for treating pain and fever in children.

The compound achieves its antipyretic effect by influencing the brain’s temperature-regulating center, promoting the return of an elevated body temperature toward a normal state. It is regarded as a core component of fundamental healthcare.

Dexamol Kid is typically supplied in dosage forms that facilitate precise administration to infants and children, such as Oral Liquid (suspension or syrup) and Suppositories. The availability of both the oral and rectal routes of administration ensures continuity of care, particularly when a child cannot tolerate oral medicine due to vomiting or severe nausea. The liquid forms are often designed with child-friendly flavors to enhance palatability and ease of intake.

Regulatory References

What side effects are possible with Dexamol Kid?

Possible side effects and safety information

The safety profile of Acetaminophen, the active ingredient in Dexamol Kid, is primarily characterized by the risk of Hepatotoxicity (severe liver damage), which is explicitly documented as a dose-dependent concern. The most significant safety constraint across official regulatory labeling is that exceeding the maximum recommended daily dose or consuming multiple acetaminophen-containing products can lead to liver failure.

Adverse reactions are formally documented and classified by frequency and the body system affected. Regulatory documents categorize certain events as Rare or Very Rare based on global reporting data.

Official Adverse Reaction Groupings

System-Organ Class	Examples of Documented Effects	Frequency Classification
Hepatobiliary Disorders	Hepatic necrosis, hepatic failure, jaundice	Dose-dependent, Rare, Very Rare
Skin and Subcutaneous	Rash, pruritus, severe skin reactions (SJS, TEN, AGEP)	Rare to Very Rare
Immune System Disorders	Anaphylactic reactions, hypersensitivity	Very Rare
Blood and Lymphatic	Blood dyscrasias (e.g., thrombocytopenia)	Not Known

Serious adverse reactions listed in official documents include Hepatotoxicity and Severe Cutaneous Adverse Reactions (SCARs). The potential for liver injury is also a consideration for patients with pre-existing conditions, as regulatory labels advise caution for those with severe hepatic impairment or severe renal impairment. For the overall safety profile, the time-related pattern of symptom onset is noted: signs of severe liver damage may be delayed, sometimes appearing 12 to 48 hours after ingestion.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for an overdose of Dexamol Kid (Acetaminophen/Paracetamol) emphasizes the need for immediate action due to the potential for severe, life-threatening outcomes.

Immediate Emergency Action

Any suspected overdose requires seeking immediate medical attention or contact with emergency services, even if the individual appears well or if early, non-specific symptoms have not yet occurred. Immediate hospitalization for comprehensive assessment and treatment is officially required following any exposure exceeding the recommended dose.

Documented Clinical Manifestations and Outcomes

Early symptoms of overdose may include non-specific signs such as nausea, vomiting, loss of appetite, and diaphoresis (sweating). These initial symptoms often precede the development of serious systemic effects. Later clinical manifestations can involve abdominal pain, jaundice, and elevated liver enzyme levels documented in laboratory tests.

The most severe, documented consequence of overdose is acute liver failure (hepatotoxicity), which may progress to hepatic necrosis, hepatic encephalopathy, coma, and eventually death. Renal tubular necrosis is also a listed outcome. Regulatory labeling notes that pre-existing liver impairment or chronic alcohol consumption are documented risk factors for increased toxicity.

Antidote and Required Monitoring

The specific antidote, N-acetylcysteine (NAC), is required for the management of toxicity and is most effective when administered within the first eight hours of ingestion. Management includes symptomatic and supportive care, along with continuous monitoring of acetaminophen plasma concentrations and liver function tests, as officially mandated by regulatory agencies.

Therapeutic Uses of Dexamol Kid

Quick Facts on Dexamol Kid's Therapeutic Use

Fever Reduction: May help reduce temporary fever.
Pain Relief: May provide temporary relief from minor aches and discomfort.

Dexamol Kid is an over-the-counter medicine used to temporarily manage fever in children. The treatment is indicated for reducing elevated body temperature, which may be associated with common ailments like the cold or flu. It may also provide temporary relief from mild to moderate pain and discomfort.

This medication is appropriate for addressing minor aches that result from common causes such as headache, toothache, minor sore throat, or symptoms related to immunizations. Managing pain and fever actively contributes to improving daily wellness for the patient. A clear understanding of the uses of this medicine in children can help support informed discussions with a healthcare professional.

Regulatory References

NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Dexamol Kid?

The eligibility for Dexamol Kid (Acetaminophen/Paracetamol) is strictly defined by regulatory authorities, focusing on age and pre-existing health conditions.

Absolute Contraindications

The medicine must not be used by individuals with a known hypersensitivity (severe allergy) to Acetaminophen or any component of the formulation. It is also absolutely contraindicated for patients diagnosed with severe hepatic impairment or active severe liver disease, as documented in official prescribing information.

Age and Conditional Use Restrictions

While Dexamol Kid is formulated for the pediatric population, its use is not recommended in infants under 3 months of age without explicit direction from a healthcare professional. Additionally, regulatory labels advise that children under 2 years of age should only use this OTC medicine after consulting a doctor.

Patients with severe renal impairment (kidney disease) or mild-to-moderate hepatic insufficiency are considered conditional users and must seek medical advice before use, as regulatory labeling requires cautious administration in these specific populations.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines interactions with Dexamol Kid (Paracetamol/Acetaminophen) as documented in official government regulatory information.

Pharmacodynamic and Metabolic Interactions

Interacting Substance/Class	Documented Interaction Effect
Oral Anticoagulants (e.g., Warfarin)	Prolonged regular use may enhance the anticoagulant effect, increasing the risk of bleeding.
Enzyme Inducers (e.g., Phenytoin, Carbamazepine, Alcohol)	May increase the formation of the toxic paracetamol metabolite, raising the risk of hepatotoxicity.

Pharmacokinetic Interactions

Interacting Substance/Class	Documented Interaction Effect
Metoclopramide and Domperidone	Increase the rate of paracetamol absorption.
Colestyramine	Reduces the rate and extent of paracetamol absorption. A minimum time separation of one hour is required.
Probenecid	Affects the clearance of paracetamol and may alter plasma concentrations.

Key Interaction-Related Constraints

It is strictly prohibited to combine Dexamol Kid with any other product containing paracetamol or acetaminophen due to the significant risk of overdose and liver damage. The official profile notes that patients with chronic malnutrition, alcoholism, or severe hypovolemia are considered populations with higher susceptibility to interaction-related hepatotoxic risks. All co-administered medicines that may affect paracetamol's metabolism or absorption must be considered by a healthcare professional.

Mechanism of Action

How Dexamol Kid Works — Mechanism of Action

This medication modulates key pathways through distinct receptor- and enzyme-mediated signaling mechanisms. It engages mechanisms that regulate overactive or dysregulated processes, influencing the resulting physiological state.

Central Pathway Modulation of Thermoregulation and Nociception

The analgesic component primarily acts within the Central Nervous System (CNS) to modulate pathways that regulate body temperature and pain perception. This mechanism is thought to involve inhibition of central Cyclooxygenase (COX) isoforms and interaction with the endocannabinoid system. This ultimately initiates a signaling sequence that resets the hypothalamic temperature set-point and dampens ascending pain signals. This process results in decreased body temperature and attenuated nociceptive signaling.

Targeted Adrenergic Signaling Affecting Nasal Vascular Tone

The decongestant component engages the Sympathetic Nervous System by acting as an agonist on alpha1-adrenergic receptors located on blood vessels in the nasal mucosa. Stimulation of these receptors modifies cellular steps, resulting in intense local vasoconstriction (narrowing of blood vessels). This limits high blood flow and capillary leakage, resulting in the physiological effect of decreased fluid extravasation and mucosal volume in the nasal and sinus tissues.

Histamine Receptor Blockade and H1 Signaling Inhibition

The antihistamine component operates by acting as a competitive antagonist at the histamine H1 receptor, preventing the binding of released histamine. This modifies the resulting cellular response in the periphery and CNS, which results in the physiological outcome of decreasing H1-mediated capillary permeability, vasodilation, and sensory nerve activation.

Dosage and Administration Information

The administration of Dexamol Kid (Acetaminophen/Paracetamol) follows specific, weight-based parameters. The medicine is intended for intermittent, short-term use and is available for two approved administration routes: Oral (liquid suspension) and Rectal (suppository).

Feature	Specification
Dosing Schedule	Administration is calculated primarily by the patient's body weight, with a standard single dose ranging from 10 mg/kg to 15 mg/kg. The total quantity administered must not exceed 60 mg/kg in a 24-hour period.
Frequency & Interval	Dosing is restricted to a minimum interval of 4 hours between administrations, with a maximum of four to five doses permitted within a 24-hour cycle.
Duration Limit	The medicine should not be used continuously for fever management for more than 3 days or for pain relief for more than 5 days without consulting a professional.

Specific procedural constraints are followed to ensure proper dosing accuracy. All liquid administration must utilize the product-specific measuring device provided, not household measuring tools, and the suspension must be shaken well prior to measurement. Administration is subject to a combination restriction, meaning the product must not be co-administered with any other medication containing acetaminophen. Furthermore, use in infants under 12 weeks requires medical consultation. These explicit instructions define the standardized pattern for the medicine's administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dexamol Kid

Evidence for Use in Reducing Fever (Antipyresis)

The primary research for the active ingredient in Dexamol Kid, Acetaminophen (Paracetamol), focuses on research exploring patterns related to high body temperature, a condition characterized by outcomes related to physiological strain or stress. This area was evaluated in high-quality study designs, including numerous Randomized Controlled Trials (RCTs) and comprehensive meta-analyses. Researchers designed these studies to monitor outcomes related to physical discomfort by measuring the continuous change in a child's body temperature over a defined time interval. The collected data show patterns related to how symptoms evolved in the observed populations, forming an extensive evidence base that is generally classified as having a High level of consistency across regulatory reviews. Long-term effects are not fully established, and evidence regarding direct comparison to non-treatment groups remains insufficient in some recent trial settings.

Evidence for Relief of Mild to Moderate Pain (Analgesia)

Research has also examined how the medicine was observed in children with temporary, episodic symptom patterns associated with minor aches and discomfort. The primary outcomes monitored were based on patient-reported outcomes describing perceived discomfort, such as pain intensity scores. Trials explored outcomes related to physical discomfort that may be associated with conditions such as headache or toothache. These trials also described outcomes related to measured patterns of change in the intensity of discomfort across short follow-up periods.

Research so far indicates that studies report how symptoms evolved in the observed populations, and the evidence is classified as High for managing general, acute discomfort. A key limitation is that follow-up durations were limited, and there is limited information for long-term outcomes for recurring pain conditions. Dependence on subjective measures introduces potential variability in study results.

What is Still Uncertain About Dexamol Kid

Despite the overall classification of High evidence for the two main uses, evidence quality varies across studies and some key limitations remain. Data for certain groups remain insufficient. Research provides context but not individual predictions, highlighting what is known—and what is still uncertain. The existing studies provide limited insight into the long-term patterns of use, as the current research primarily explores short-term symptom changes over defined, limited intervals.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Dexamol Kid (FAQ)

Q: What age range is Dexamol Kid generally used for?

A: The medicine is primarily intended for the pediatric population. According to official dosing instructions, the specific weight-based charts often cover children up to 12 years of age. Dosing guidelines for individuals over this age may differ.

Q: Can Dexamol Kid be given to infants under 6 months?

A: Official documents state that use in this age range requires consultation with a healthcare professional before administration. This requirement is consistent with the general regulatory recommendation for children under 2 years of age when using over-the-counter medication.

Q: Is it safe to use Dexamol Kid alongside multivitamins?

A: Regulatory documents primarily detail interactions with prescription medications that can affect how the body processes the active ingredient. Official labeling describes the importance of a healthcare professional being informed of all supplements taken, including multivitamins.

Q: Can Dexamol Kid be used if a child has asthma?

A: Asthma is not listed as an absolute contraindication in the official prescribing information for this medicine. The regulatory labels emphasize conditional use warnings for specific pre-existing conditions, particularly severe liver or kidney impairment.

Q: Is Dexamol Kid appropriate for children with kidney issues?

A: Official regulatory labels indicate that patients with severe renal impairment (kidney disease) are considered conditional users. Regulatory documents state that consultation with a healthcare professional is required before use, as cautious administration is necessary.

Q: Has liver-related side effects been reported with Dexamol Kid?

A: Yes, Hepatotoxicity (severe liver damage) is explicitly documented in regulatory information as a dose-dependent concern. Severe outcomes such as hepatic necrosis and liver failure are listed among the Rare or Very Rare adverse reactions in official safety profiles.

Q: Can Dexamol Kid interact with herbal supplements?

A: Official labeling advises caution for co-administration with any substance that is documented as affecting the liver enzyme pathways. Regulatory documents emphasize the importance of reporting all co-administered supplements, including herbal products.

Q: What are the general expectations regarding pain relief from Dexamol Kid?

A: The medicine is described in official documents as an analgesic for the relief of mild to moderate pain and discomfort. Research has examined short-term changes in the intensity of discomfort following administration.

Q: Does Dexamol Kid contain sugar or artificial sweeteners?

A: Official labeling for liquid and chewable acetaminophen products advises checking the inactive ingredients list. Some formulations may contain aspartame, which is a source of phenylalanine and requires consideration for patients with phenylketonuria (PKU).

Q: Is it typical for Dexamol Kid to be prescribed after minor surgery?

A: The medicine is officially documented for the relief of minor aches and discomfort. This broad classification includes various forms of acute, temporary pain.

Q: How quickly is Dexamol Kid expected to start working?

A: Clinical pharmacological data indicates that the onset of action for oral administration is generally documented to occur within one hour.

Q: What is the typical duration of effect for Dexamol Kid?

A: Studies and official information indicate that the duration of the analgesic (pain-relieving) and antipyretic (fever-reducing) effect is typically documented to last between 4 and 6 hours.

Q: Why is Dexamol Kid given in liquid form?

A: Liquid and suppository formulations are primarily designed to facilitate precise, weight-based dosing for the pediatric population. The liquid form is also created to enhance palatability and ease of administration in children.

Q: Are there different flavors of Dexamol Kid?

A: According to official documentation describing the dosage form, the oral suspension of the medicine is often produced in different flavors to help improve acceptance by children.

Q: Can Dexamol Kid cause drowsiness in children?

A: Regulatory documentation for the single-ingredient acetaminophen product does not list drowsiness as a core adverse reaction. Drowsiness warnings are typically associated with combination products containing antihistamines.

Q: Is Dexamol Kid considered an NSAID?

A: The medicine is classified as an Analgesic (pain reliever) and Antipyretic (fever reducer). It is not generally classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) because its anti-inflammatory effects are considered minor.

Q: Why is Dexamol Kid categorized as a Schedule 3 medicine?

A: Single-ingredient acetaminophen products like Dexamol Kid are widely available over-the-counter and are not classified as a controlled substance by regulatory agencies. The Schedule III classification applies only to certain combination products that contain an opioid.

Q: Does Dexamol Kid treat the cause of the fever?

A: Official documents describing the mechanism of action indicate that the medicine acts by modulating the body's temperature set-point in the central nervous system. It is not documented to treat the underlying cause of the fever, such as a viral or bacterial infection.

Q: Can Dexamol Kid be used for muscle pain or sprains?

A: Yes, official documents list the relief of minor aches and pains as an approved use. This includes temporary discomfort associated with conditions such as muscular aches.

Q: Can Dexamol Kid be used when a child is also taking flu medication?

A: Official labeling explicitly constrains co-administration of the medicine with any other product, including flu remedies, that also contain acetaminophen. This restriction is in place due to the significant risk of exceeding the maximum recommended dose.

Q: Is there a risk of interaction between Dexamol Kid and common cold remedies?

A: Yes, the primary risk of interaction comes from cold remedies that contain the same active ingredient (acetaminophen). Official labeling explicitly constrains the combination of this medicine with cold remedies that contain the same active ingredient.

Q: Does the efficacy of Dexamol Kid vary by age group?

A: Official regulatory bodies establish dosing based on age and body weight to ensure the appropriate concentration is administered across different pediatric groups. This process is designed to achieve the intended efficacy within the defined population.

Q: Are there known effects of Dexamol Kid on sleep patterns?

A: Official regulatory documentation for the single-ingredient acetaminophen product does not typically list effects on sleep patterns as a core adverse reaction in the established safety profile.

Q: Can Dexamol Kid be given if a child has recently been vaccinated?

A: The medicine is approved for the temporary relief of fever and minor pain, which may include symptoms that occur following a vaccination.

Q: Is it described in official sources that Dexamol Kid can be taken on an empty stomach?

A: Official instructions for use do not include a specific requirement to take the medicine with food. The primary focus of the label is on ensuring the correct dose is administered at the specified minimum time interval.

How should Dexamol Kid be stored and disposed of?

Storage and Disposal Conditions for Dexamol Kid

All storage and disposal procedures for Dexamol Kid must strictly adhere to the conditions documented in government-approved regulatory labeling.

Required Storage and Protection

The medicine must be stored at a temperature that does not exceed 25 C and should be kept in a dry place away from direct sunlight. The product must remain in its original, tightly closed container.

Child Safety and Stability

It is a mandatory regulatory requirement to keep this medicine out of the reach and sight of children and infants to prevent poisoning. Do not use the medicine after the expiry date stated on the package. For liquid forms, use may be permitted until the printed expiry date, even after opening.

Disposal

Unused or expired product must be disposed of in accordance with local regulations, ensuring it is not consumed by pets or unauthorized persons. Do not dispose of the medicine by flushing it down a toilet or pouring it into a drain.

Dexamol Kid